{"authors": [["Murata", "Takashi", "T", "1 Diabetes Center, National Hospital Organization Kyoto Medical Center, Fushimi-ku, Kyoto, Japan."], ["Sakane", "Naoki", "N", "2 Division of Preventive Medicine, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Fushimi-ku, Kyoto, Japan."], ["Kato", "Ken", "K", "1 Diabetes Center, National Hospital Organization Kyoto Medical Center, Fushimi-ku, Kyoto, Japan."], ["Tone", "Atsuhito", "A", "3 Diabetes Center, Okayama University Hospital, Kita-ku, Okayama, Japan."], ["Toyoda", "Masao", "M", "4 Division of Nephrology, Endocrinology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan."]], "text": "", "id": "29281891", "date": "2017-12-01", "title": "The Current Intermittent-Scanning CGM Device Situation in Japan: Only Adjunctive Use to SMBG Is Approved and the Latest Health Insurance Coverage Details.", "doi": "10.1177/1932296817749860", "journal": ["Journal of diabetes science and technology", "J Diabetes Sci Technol"]}